MODERATOR
:
SPEAKER
(S):
Dr. Nancy Heddle, MSc, FCSMLS(D), Research Director, McMaster Centre for Transfusion Research, McMaster University
Hannes Wandt, MD, Head of BMT-Unit, Medical Clinic 5, Klinikum Nuremberg,/Germany
Hot Topic: Are Prophylactic Platelet Transfusions History?
Sunny Dzik, MD, Co-Director, Blood Transfusion Service, Massachusetts General Hospital
Prophylactic platelets: past, present, future
Simon Stanworth, FRCP, FRCPath, DPhil, Consultant Hematologist, NHSBT
Description
The hot topic session addresses a transfusion practice issue that has been debated for many years: should we be giving prophylactic platelet transfusion therapy to hematology/oncology patients who have chemotherapy induced thrombocytopenia or is a therapeutic only strategy safe? 2012 was a landmark year for transfusion medicine with the results of two randomized controlled trials addressing this issue being reported: a study from Germany; and the international TOPPS trial lead by researchers in the UK. This session will explore the designed and results of these two trials, their similarities and differences and discussions/debates around changing practice and the need for future research.
Simon Stanworth did not give consent to be recorded.
-
Assess the design and results of two recently published randomized controlled trials evaluating a therapeutic platelet transfusion strategy and the implication of these studies for transfusion practice.
-
Identify the differences and similarities of the two studies.
-
Review challenges associated with knowledge translation and explore the need for future research.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.